From Models to Meaning: The Integrator Pharmacologist's Role in Advancing Health Equity Across the Drug Development Continuum

Modeling and simulation strategies have evolved from supportive analytical tools to central decision-making engines across drug discovery, development, and regulatory science. By integrating data, models, and stakeholder perspectives, integrator pharmacologists ensure that early discovery decisions translate into robust clinical strategies, meaningful benefit-risk assessments, and ultimately, patient access. This reflection underscores how equity-focused quantitative thinking will pave the path for the next generation of translational science.